Open Access · CC BY-NC 3.0
Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases
Biologics: Targets and Therapy · 2012-08 · 277
DOI: 10.2147/btt.s25188 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biologics: Targets and Therapy, 2012-08. Verfasst von Lisa Kobrynski. Beteiligte Einrichtung: Department of Pediatrics, Emory University, Atlanta, GA, USA. Die Arbeit wurde bisher 28-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
immunoglobulin Gprimary immunodeficiency diseasessubcutaneous immunoglobulin
Autor:innen und Institutionen
- Department of Pediatrics, Emory University, Atlanta, GA, USA.
Zitieren
APA
Kobrynski, L. (2012). Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases. Biologics: Targets and Therapy, 277. https://doi.org/10.2147/btt.s25188
Vancouver
Kobrynski L. Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases. Biologics: Targets and Therapy. 2012:277. doi:10.2147/btt.s25188
BibTeX
@article{Kobrynski2012,
author = {Kobrynski, Lisa},
title = {Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases},
journal = {Biologics: Targets and Therapy},
year = {2012},
pages = {277},
doi = {10.2147/btt.s25188}
}
EUVIMED